These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 1940305

  • 1. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R.
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
    Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, DeArmond SJ, Prusiner SB.
    Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
    [Abstract] [Full Text] [Related]

  • 5. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K.
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [Abstract] [Full Text] [Related]

  • 6. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
    Moss J, Shore I, Woodrow D.
    Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
    [Abstract] [Full Text] [Related]

  • 7. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G, Elliott-Bryant R, Phung N, Vitseva O, Kuberan B, Lech M.
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
    Niewold TA, Flores Landeira JM, van den Heuvel LP, Ultee A, Tooten PC, Veerkamp JH.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 Dec; 60(5):321-8. PubMed ID: 1685039
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T, Magnus JH, Husby G.
    Biochem J; 1994 Oct 15; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [Abstract] [Full Text] [Related]

  • 13. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN.
    Am J Pathol; 1988 Dec 15; 133(3):456-63. PubMed ID: 2974240
    [Abstract] [Full Text] [Related]

  • 14. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
    Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, Metzger S, Vlodavsky I, Kisilevsky R, Lindahl U.
    Proc Natl Acad Sci U S A; 2005 May 03; 102(18):6473-7. PubMed ID: 15843464
    [Abstract] [Full Text] [Related]

  • 15. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L, Kisilevsky R, Young ID.
    Lab Invest; 1993 Oct 03; 69(4):443-8. PubMed ID: 8231112
    [Abstract] [Full Text] [Related]

  • 16. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.
    Westermark GT, Norling B, Westermark P.
    Clin Exp Immunol; 1991 Oct 03; 86(1):150-6. PubMed ID: 1914228
    [Abstract] [Full Text] [Related]

  • 17. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
    Inoue S, Hultin PG, Szarek WA, Kisilevsky R.
    Lab Invest; 1996 Jun 03; 74(6):1081-90. PubMed ID: 8667612
    [Abstract] [Full Text] [Related]

  • 18. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T, Husby G.
    J Rheumatol; 1996 Jan 03; 23(1):93-100. PubMed ID: 8838515
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.
    Nelson SR, Lyon M, Gallagher JT, Johnson EA, Pepys MB.
    Biochem J; 1991 Apr 01; 275 ( Pt 1)(Pt 1):67-73. PubMed ID: 1902087
    [Abstract] [Full Text] [Related]

  • 20. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
    Inoue S, Kawano H, Ishihara T, Maeda S, Ohno S.
    Amyloid; 2005 Sep 01; 12(3):157-63. PubMed ID: 16194870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.